TSP Capital Management Group LLC Sells 11,701 Shares of Xylem Inc. $XYL

TSP Capital Management Group LLC trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 11.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,232 shares of the industrial products company’s stock after selling 11,701 shares during the period. Xylem accounts for about 3.5% of TSP Capital Management Group LLC’s investment portfolio, making the stock its 13th biggest holding. TSP Capital Management Group LLC’s holdings in Xylem were worth $13,014,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. SJS Investment Consulting Inc. lifted its stake in shares of Xylem by 1,844.4% in the 3rd quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock valued at $26,000 after purchasing an additional 166 shares during the period. Maseco LLP bought a new stake in Xylem in the second quarter valued at about $31,000. ST Germain D J Co. Inc. boosted its holdings in Xylem by 950.0% during the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after buying an additional 228 shares during the last quarter. Signature Resources Capital Management LLC acquired a new position in shares of Xylem during the 2nd quarter worth about $39,000. Finally, Caldwell Trust Co bought a new stake in shares of Xylem in the 2nd quarter valued at about $41,000. 87.96% of the stock is owned by institutional investors.

Xylem Stock Up 0.7%

XYL stock opened at $137.12 on Monday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50. The stock has a market capitalization of $33.38 billion, a P/E ratio of 35.25, a P/E/G ratio of 1.94 and a beta of 1.17. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The business has a 50-day moving average of $142.18 and a 200-day moving average of $140.32.

Xylem (NYSE:XYL) last released its earnings results on Tuesday, October 28th. The industrial products company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.23 by $0.14. The firm had revenue of $2.27 billion for the quarter, compared to analysts’ expectations of $2.22 billion. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The business’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, sell-side analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.

Xylem Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were paid a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio is currently 41.13%.

Insider Activity

In other Xylem news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the transaction, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This trade represents a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total value of $251,838.00. Following the sale, the director owned 16,875 shares in the company, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.27% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the stock. Weiss Ratings restated a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. UBS Group boosted their price target on shares of Xylem from $168.00 to $175.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Cowen restated a “hold” rating on shares of Xylem in a research report on Friday, December 5th. Wall Street Zen cut Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, December 27th. Finally, Royal Bank Of Canada raised their price target on Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Eight equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $167.40.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.